BioStock: The five best life science stocks of the first half-year

July 5, 2023
Language flag

PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.

This great acknowledgment comes from Biostock, Scandinavia’s leading digital news and analysis service for the Life Science sector. PHI’s performance has been recognized alongside the life science companies Prolight Diagnostics, Saniona, Lipidor, and Ziccum.

Our team is honored to feature on this top list. And we remain committed to advancing our innovative solutions for non-invasive cell analysis and quality control in regenerative medicine.

Read the full article on biostock.se.

Latest News

Peter Egelberg CEO PHI

Founder and board member subscribes for shares in the ongoing rights issue

Peter Egelberg, founder and Board member of Phase Holographic Imaging PHI AB has notified the Company that he, together with closely related parties, follows Altium SA’s lead by subscribing for shares in the Company’s ongoing fully secured rights issue. The subscription amounts to approximately 300 TSEK.
AndersMansson-web

PHI at Aktieportföljen Live, BioStock and Financial Stockholm

The subscription period in PHI AB’s fully secured rights issue, totalling SEK 64.3 million, is ongoing until 20 December 2024. The Company’s CEO, Anders Månsson, has during the last couple of weeks presented the Company and its future plans. For links to the presentations and the podcast, see below.

Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ) 8 January 2025

The shareholders of Phase Holographic Imaging PHI AB (publ), (“the Company”), reg.no. 556542-7811, are hereby invited to attend the general meeting on 8 January 2025 at 15.00 at the Company´s office at Skiffervägen 48 in Lund.
See All News